Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Zanamivir. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel arabinose-based route reduces cost and improves scalability for high-purity antiviral intermediate manufacturing supply chains globally.
Novel one-step synthesis of zanamivir derivative offers high yield and simplified process for pharmaceutical intermediates supply chain optimization.
Patent CN111018901A reveals a novel synthetic route for Zanamivir and Laninamivir intermediates, offering enhanced purity and cost-effective manufacturing solutions.